Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like they did in the case of Zevra Therapeutics, Inc. (NASDAQ:ZVRA), that sends out a ...
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are ...
A number of first-in-disease, first-in-class and first-in-modality drugs approved last year have redefined therapeutic areas, ...
Copyright © 2025 MarketWatch, Inc. All rights reserved.
GLUE Monte Rosa Therapeutics, Inc.
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback